Literature DB >> 21155887

Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.

Swapna Mahurkar1, Rupa Banerjee, Vasantha S Rani, Nikita Thakur, Guduru Venkat Rao, Duvvuru Nageshwar Reddy, Giriraj R Chandak.   

Abstract

BACKGROUND AND AIM: Ulcerative colitis (UC) and Crohn's disease (CD) are two major phenotypes of inflammatory bowel disease (IBD) that present with inflammation of the colon or the entire gastrointestinal tract, respectively. Genome-wide association studies have confirmed the role of nucleotide-binding oligomerization domain protein-2 (NOD2) variants and identified several other genes associated with IBD. We investigated whether variants in NOD2 and interleukin-23 receptor (IL23R) are associated with IBD in a well-characterized case-control cohort from southern India.
METHODS: We recruited 652 patients (411 UC and 241 CD) using established diagnostic criteria and 442 age-, sex-, and ethnically-matched, normal individuals. By direct sequencing, we screened the complete NOD2 gene and genotyped the R381Q variant in IL23R, and performed an association analysis and genotype-phenotype correlation analysis.
RESULTS: The clinical presentation of UC and CD patients did not differ significantly from the Europeans. We observed a monomorphic status for three common disease-susceptible variants, R702W, G908R, and 1007fs in NOD2; three other single nucleotide polymorphisms, P268S, R459R, and R587R, had a comparable minor allele frequency in patients and controls. Compared to Europeans, we found a low frequency (∼1%) of the protective allele at R381Q in IL23R and no statistically-significant association with IBD (odds ratio = 0.87; 95% confidence interval = 0.26-2.86; P>0.05).
CONCLUSIONS: Our study suggests that variants in the NOD2 gene and the protective variant R381Q in IL23R are not associated with IBD in Indians. Additional variants in these or other candidate genes might play a major role in the pathophysiology of IBD in Indians.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21155887     DOI: 10.1111/j.1440-1746.2010.06533.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  18 in total

1.  NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103+ dendritic cells.

Authors:  David Prescott; Charles Maisonneuve; Jitender Yadav; Stephen J Rubino; Stephen E Girardin; Dana J Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-29       Impact factor: 11.205

2.  Indian Society of Gastroenterology consensus statements on Crohn's disease in India.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Vineet Ahuja; Uday C Ghoshal; Venkataraman Jayanthi; Benjamin Perakath; Philip Abraham; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Mathew Philip; Anna Pulimood; Amarender S Puri; Gautam Ray; Shivaram P Singh; Ajit Sood; Venkatraman Subramanian
Journal:  Indian J Gastroenterol       Date:  2015-03-14

Review 3.  Environmental triggers for IBD.

Authors:  Aoibhlinn O'Toole; Joshua Korzenik
Journal:  Curr Gastroenterol Rep       Date:  2014

4.  Association between NOD2/CARD15 gene polymorphisms and Crohn's disease in Chinese Zhuang patients.

Authors:  Wei-Yan Long; Lan Chen; Cui-Liang Zhang; Rong-Mao Nong; Mei-Jiao Lin; Ling-Ling Zhan; Xiao-Ping Lv
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Inflammatory bowel disease in India: challenges and opportunities.

Authors:  Alice Snell; Jonathan Segal; Jimmy Limdi; Rupa Banerjee
Journal:  Frontline Gastroenterol       Date:  2020-07-14

Review 6.  Genetics of Inflammatory Bowel Diseases.

Authors:  Dermot P B McGovern; Subra Kugathasan; Judy H Cho
Journal:  Gastroenterology       Date:  2015-08-07       Impact factor: 22.682

7.  NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.

Authors:  Zhenwu Lin; John P Hegarty; Gerrit John; Arthur Berg; Zhong Wang; Rishabh Sehgal; Danielle M Pastor; Yunhua Wang; Leonard R Harris; Lisa S Poritz; Stefan Schreiber; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2013-05-26       Impact factor: 3.199

8.  Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.

Authors:  Umang Arora; Saurabh Kedia; Prerna Garg; Sawan Bopanna; Saransh Jain; Dawesh P Yadav; Sandeep Goyal; Vipin Gupta; Peush Sahni; Sujoy Pal; Nihar Ranjan Dash; Kumble Seetharama Madhusudhan; Raju Sharma; Govind Makharia; Vineet Ahuja
Journal:  Dig Dis Sci       Date:  2018-04-02       Impact factor: 3.199

Review 9.  Crohn's and colitis in children and adolescents.

Authors:  Andrew S Day; Oren Ledder; Steven T Leach; Daniel A Lemberg
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

Review 10.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.